Publications and Research


​1. Gevirtz, R.N., Alhassoon, O.M., & Miller, B.P. (in press). Biomedical treatments. In J. C. Norcross, G. R. VandenBos, & D. K. Freedheim (Editors-in-Chief), R. Krishnamurthy (Associate Editor), APA handbook of clinical psychology: Vol. 3. Applications and methods. Washington, DC: American Psychological Association.

2. Sub-Investigator Sharp HealthCare. Janssen Care 4 Today Protocol. Utilizing Mobile Health Technology in the treatment of patients with Schizophrenia and Schizoaffective on long-acting injectable antipsychotics. 2015.

3. Miller BP, Garces-Barrella N, RN. Treatment of Catatonia in the Medical ICU with ECT: Delay in Treatment due to Legal “Protections” in California. Poster Presentation at the International Society for ECT and Neurostimulation (ISEN), New York, May 2014.

4. Miller BP. TMS in a Patient with Bipolar Depression Following ECT. Poster Presentation at the U.S Psychiatric and Mental Health Conference, San Diego, Nov 2012.

5. Miller BP, Hoyt L, Allred K. Evaluating the Effectiveness of a Psychosocial Rehabilitation Program for Persons with Severe and Persistent Mental Illness. Poster Presentation at The Meeting of the Minds, San Diego, 2008.

6. Miller BP, Giordano R. Creating a Suicide Risk Assessment Tool for use in the Emergency Department. Poster Presentation at the American Psychiatric Association, San Diego, May 2007.

7. Miller BP, Hoyt L, Allred K. Evaluating the Effectiveness of a Psychosocial Rehabilitation Program for Persons with Severe and Persistent Mental Illness. Poster Presentation at the Institute of Psychiatry, San Diego, Oct 2007.

8. Miller BP, Adams R. Electroconvulsive Therapy: A 12-Month Sample from a Community Hospital. Poster Presentation at the Institute of Psychiatric Services, San Diego, October 2005.

9. Miller BP, Perry W, Moutier C, Robinson S, Feifel D. Rapid oral loading of extended release divalproex in patients with acute mania.
General Hospital Psychiatry, 2005, May-June, 27(3): 218-221.

10. Miller BP, Perry W, Moutier C, Robinson S, Feifel D. Safety and Tolerability of Rapid-Loading Extended Release Divalproex Sodium. Poster Presentation at the APA, New Orleans, May 2001.

11. Matthews SC, Miller BP. Auditory Hallucinations Associated with Topiramate. J Clin Psychiatry, 2001, August, 62(8):653.

12. Servis M, Miller B. Treatment of Psychosis with Prochlorperazine in the ICU setting. Psychosomatics, 1997, Nov-Dec, 38(6):589-90.

13. Principle Investigator, Sharp HealthCare. Bristol-Meyers-Squib Protocol CN138113…Three Fixed Doses of Aripiprazole in the Treatment of Patients with Acute Schizophrenia. 2003.

14. Sub-Investigator, UCSD site for STAR*D. NIMH-funded Sequenced Treatment Alternatives to Relieve Depression, under direction of Sidney Zisook, MD. 2003-2004.

15. Sub-Investigator, Sharp HealthCare. Multiple Phase III and Phase IV trials involving Schizophrenia, Schizoaffective Disorder, Mania, Agitation, and Dementia. Principal Investigator Michael Plopper, MD. 2001-present.

16. Sub-Investigator UCSD, Astra-Zeneca Protocol 5077IL/0099… Safety and Efficacy of Seroquel as Add-on Therapy with Lithium or Divalproex in the Treatment of Acute Mania. 2001.

17. Sub-Investigator UCSD, Eli-Lilly Protocol B4Z-MC-LYAA…Tomoxetine Hydrochloride in Adults Outpatients with DSM-IV Attention-Deficit/Hyperactivity Disorder. 2001.

18. Sub-Investigator UCSD, Eli-Lilly Protocol B4Z-MC-LYAB…Tomoxetine Hydrochloride in Outpatients with ADHD, Ages 6 to 18 Years. 2001.

19. Sub-Investigator UCSD, Eli-Lilly Protocol B4Z-MC-LYAR(a). Long-Term, Open-Label Safety Study of Tomoxetine Hydrochloride in Adult Outpatients with DSM-IV Attention-Deficit/Hyperactivity Disorder. 2000.

20. 1999-2000 Team Physician, UCSD Dual Diagnosis Demonstration Project. Led a multidisciplinary team in the treatment of patients with severe dual diagnosis’ using leading edge practices as part of a research project performed in conjunction with the county of San Diego.

21. Research Assistant, UC Davis Department of Neuroscience. Assisted with investigations on sodium channel activity in mammalian retinal cells 1991-1992.